Hestia Insight Inc.
HSTA
Other OTC0.04
USD
- -
- -
CIK
0001813603
ISIN
US42815H1095
CUSIP
42815H109
Return %
Stock
S&P500
1Y
-62.00
26.84
3Y
-93.03
77.03
5Y
-99.27
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Edward C. Lee
- Full Time Employees
- 3
- Sector
- Technology
- Industry
- Software - Application
- Address
- 400 South 4th Street Las Vegas NV United States of America 89101
- IPO Date
- Sep 18, 2009
- CIK
- 0001813603
- Website
- hestiainsight.com
- Similar Companies
- Business
- Hestia Insight Inc. (HSTA) operates as an AI-powered capital markets advisory and business consulting firm, specializing in comprehensive fundraising solutions for emerging growth companies, startups, small businesses, and growth-stage entities. The company offers AI-enhanced services encompassing pre-raise strategy development including minimum viable product creation and intellectual property protection; comprehensive market research and financial modeling; preparation of investor-ready materials such as pitch decks, executive summaries, video demos, legal documents, and due diligence support; end-to-end investor outreach and relations management; fractional C-suite services including chief strategy officer and chief financial officer support; strategic planning; mergers and acquisitions advisory; IPO consulting; capital market advisory; and technology transfer services. Through its wholly owned subsidiaries Hestia Investments Inc. and HSTA Health Inc., it maintains a strategic focus on the healthcare and biotech sectors, providing medical supply sales and marketing support, management consulting, patient services, development of healthcare technologies for neurological and psychiatric disorders, and operations in healthy food, beverage, wellness products, and smart vending machines, while expanding AI-powered advisory across all industry verticals. The firm pursues strategic acquisitions, licensing, joint ventures, and direct investments in emerging growth companies with unique sciences and technologies, particularly in healthcare and biotech, and targets small and mid-sized private and public companies across the United States, Asia including Greater China, Europe, the Middle East, Latin America, and Israel. Founded on November 19, 2003, and headquartered in Las Vegas, Nevada, with additional offices in New York, New York; Shanghai, China; and Taipei, Taiwan, Hestia Insight Inc. changed its name from Luxshmi Investments Inc. on March 27, 2019. Recent developments include a May 2025 partnership between its subsidiary Hestia Investments Inc. and RG Robotix for IPO consulting, business development, and management consulting services to support the robotics firm's public offering and growth; a corporate advisory agreement with Aquiva Medical Inc.; a letter of intent with Noether Sciences and Technologies Inc. (NSAT) to establish an exclusive partnership for research, commercialization, and licensing of neurotherapy protocols for depression and anxiety, including plans for neurotherapy clinics in New York City and other areas; a strategic pivot away from vending operations toward AI-driven advisory leadership; and approval of a capital raise of up to $5 million through equity and/or convertible debt to fund AI team expansion, research and development, marketing, and general corporate purposes.
Hestia Insight Inc. Launches Impact-O AI Suite: Elite News Drafting and Compliance Screening for an Introductory $179
Hestia Insight Inc. Issues Letter to Shareholders on Strategic Transformation
Hestia Insight Inc. Subsidiary Enters Into Corporate Advisory Agreement With Aquiva Medical Inc.
Hestia Insight Inc. Unveils Innovative Marketing Plan to Assist Emerging Companies
Hestia Insight Inc. Announces Upcoming Launch of AI-Powered IR Website Platform to Assist Start-Ups, Small and Medium Sized Companies